Skip to content
10-Q

Quarterly Report

AbCellera Biologics Inc. ABCL

0001703057-25-000025

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 299.34M sh
Shares Diluted Q3 2025 · Sep 30, 2025 298.88M sh
Shares Diluted Q3 2025 · Sep 30, 2025 298.37M sh
Shares Diluted Q3 2025 · Sep 30, 2024 294.85M sh
Shares Diluted Q3 2025 · Sep 30, 2024 293.93M sh
Capex Q3 2025 · Sep 30, 2025 $32.93M
Capex Q3 2025 · Sep 30, 2024 $62.77M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$96.55M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$100.56M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $83.16M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $156.33M
Stockholders Equity Q3 2025 · Sep 30, 2025 $964.04M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.01B
Stockholders Equity Q3 2025 · Mar 31, 2025 $1.02B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.06B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.08B
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.11B
Stockholders Equity Q3 2025 · Mar 31, 2024 $1.13B
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.15B
Current Liabilities Q3 2025 · Sep 30, 2025 $68.8M
Current Liabilities Q3 2025 · Dec 31, 2024 $76.61M
Total Liabilities Q3 2025 · Sep 30, 2025 $391.95M
Total Liabilities Q3 2025 · Dec 31, 2024 $304.47M
Current Assets Q3 2025 · Sep 30, 2025 $695.14M
Current Assets Q3 2025 · Dec 31, 2024 $751.37M
Total Assets Q3 2025 · Sep 30, 2025 $1.36B
Total Assets Q3 2025 · Dec 31, 2024 $1.36B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.19
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.46
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.17
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.44
Eps Basic Q3 2025 · Sep 30, 2025 −$0.19
Eps Basic Q3 2025 · Sep 30, 2025 −$0.46
Eps Basic Q3 2025 · Sep 30, 2024 −$0.17
Eps Basic Q3 2025 · Sep 30, 2024 −$0.44
Rd Expense Q3 2025 · Sep 30, 2025 $55.03M
Rd Expense Q3 2025 · Sep 30, 2025 $136.74M
Rd Expense Q3 2025 · Sep 30, 2024 $40.97M
Rd Expense Q3 2025 · Sep 30, 2024 $121.18M
Net Income Q3 2025 · Sep 30, 2025 −$57.12M
Net Income Q3 2025 · Sep 30, 2025 −$137.47M
Net Income Q3 2025 · Jun 30, 2025 −$34.73M
Net Income Q3 2025 · Mar 31, 2025 −$45.62M
Net Income Q3 2025 · Sep 30, 2024 −$51.11M
Net Income Q3 2025 · Sep 30, 2024 −$128.65M
Net Income Q3 2025 · Jun 30, 2024 −$36.93M
Net Income Q3 2025 · Mar 31, 2024 −$40.61M
Operating Income Q3 2025 · Sep 30, 2025 −$76.28M
Operating Income Q3 2025 · Sep 30, 2025 −$188.52M
Operating Income Q3 2025 · Sep 30, 2024 −$93.66M
Operating Income Q3 2025 · Sep 30, 2024 −$242.01M
Revenue Q3 2025 · Sep 30, 2025 $8.96M
Revenue Q3 2025 · Sep 30, 2025 $30.28M
Revenue Q3 2025 · Sep 30, 2024 $6.51M
Revenue Q3 2025 · Sep 30, 2024 $23.78M